92 related articles for article (PubMed ID: 18234542)
1. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
2. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.
Bau DT; Lippman SM; Xu E; Gong Y; Lee JJ; Wu X; Gu J
Cancer; 2013 Dec; 119(24):4277-83. PubMed ID: 24105340
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
4. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
[TBL] [Abstract][Full Text] [Related]
5. Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand.
Thongsuksai P; Boonyaphiphat P; Puttawibul P; Sudhikaran W
World J Gastroenterol; 2010 Nov; 16(42):5359-66. PubMed ID: 21072901
[TBL] [Abstract][Full Text] [Related]
6. Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.
Li H; Liu Y; Zhou S; Zhou Q; Yang X
BMC Oral Health; 2023 Sep; 23(1):659. PubMed ID: 37697274
[TBL] [Abstract][Full Text] [Related]
7. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.
Li B; Chen X; Xian H; Wen Q; Wang T
PeerJ; 2023; 11():e16392. PubMed ID: 38050610
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and apoptosis markers in oral submucous fibrosis.
Ranganathan K; Kavitha R
J Oral Maxillofac Pathol; 2011 May; 15(2):148-53. PubMed ID: 22529572
[TBL] [Abstract][Full Text] [Related]
9. Genetic associations between gene polymorphisms on 3p25 and oral squamous cell carcinoma.
Yuan M; Zheng X; Jing J; Li Y; Liu N; Song Y
Oral Dis; 2024 Apr; 30(3):1018-1031. PubMed ID: 36680374
[TBL] [Abstract][Full Text] [Related]
10. The Interaction between CLSPN Gene Polymorphisms and Alcohol Consumption Contributes to Oral Cancer Progression.
Hsieh MJ; Lo YS; Ho HY; Lin CC; Chuang YC; Chen MK
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256171
[TBL] [Abstract][Full Text] [Related]
11. Microbiome and oral squamous cell carcinoma: a possible interplay on iron metabolism and its impact on tumor microenvironment.
Arthur RA; Dos Santos Bezerra R; Ximenez JPB; Merlin BL; de Andrade Morraye R; Neto JV; Fava NMN; Figueiredo DLA; de Biagi CAO; ; Montibeller MJ; Guimarães JB; Alves EG; Schreiner M; da Costa TS; da Silva CFL; Malheiros JM; da Silva LHB; Ribas GT; Achallma DO; Braga CM; Andrade KFA; do Carmo Alves Martins V; Dos Santos GVN; Granatto CF; Terin UC; Sanches IH; Ramos DE; Garay-Malpartida HM; de Souza GMP; Slavov SN; Silva WA
Braz J Microbiol; 2021 Sep; 52(3):1287-1302. PubMed ID: 34002353
[TBL] [Abstract][Full Text] [Related]
12. Association between coca (Erythroxylum coca) chewing habit and oral squamous cell carcinoma: a case-control study from Argentina.
Molina-Ávila I; Pimentel-Solá JM; Buschiazzo E; Echazú A; Piemonte E; Gilligan G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Apr; ():. PubMed ID: 38782674
[TBL] [Abstract][Full Text] [Related]
13. Impact of
Hsu HT; Lu YT; Chen YT; Hsing MT; Su CW; Su SC; Lin CW; Yang SF
J Cancer; 2024; 15(8):2354-2360. PubMed ID: 38495489
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of circulating estrogen in oral leukoplakia and oral squamous cell carcinoma.
Thakare E; Chaudhary M; Gadbail A
J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102904
[TBL] [Abstract][Full Text] [Related]
15. Differences in modifiable factors of oral squamous cell carcinoma in the upper and lower of oral fissure.
Yan L; Chen F; Liu F; Qiu Y; Wang J; Wu J; Bao X; Hu Z; Peng X; Lin X; Cai L; Lin L; He B
Oncotarget; 2017 Sep; 8(43):75094-75101. PubMed ID: 29088848
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Genetic Polymorphisms in Glutathione S-Transferase Theta1, Glutathione S-Transferase Mu1, and Glutathione S-Transferase Mu3 in Oral Leukoplakia and Oral Squamous Cell Carcinoma with Deleterious Habits using Polymerase Chain Reaction.
Rao AK; Parameswar P; Majumdar S; Uppala D; Kotina S; Vennamaneni NH
Int J Appl Basic Med Res; 2017; 7(3):181-185. PubMed ID: 28904918
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date.
Shridhar K; Aggarwal A; Walia GK; Gulati S; Geetha AV; Prabhakaran D; Dhillon PK; Rajaraman P
Oral Oncol; 2016 Oct; 61():146-51. PubMed ID: 27688118
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk.
Anantharaman D; Samant TA; Sen S; Mahimkar MB
Oral Oncol; 2011 Sep; 47(9):866-72. PubMed ID: 21741876
[TBL] [Abstract][Full Text] [Related]
19. Effect of polymorphisms in XRCC1, CCND1 and GSTM1 and tobacco exposure as risk modifier for oral leukoplakia.
Yadav BK; Kaur J; Srivastava A; Ralhan R
Int J Biol Markers; 2009; 24(2):90-8. PubMed ID: 19634112
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions.
Ye Y; Lippman SM; Lee JJ; Chen M; Frazier ML; Spitz MR; Wu X
Cancer; 2008 Nov; 113(9):2488-95. PubMed ID: 18823025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
